A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Triple-negative Breast Cancer|Locally Advanced Triple-negative Breast Cancer
Interventions: DRUG: AK117|DRUG: AK112|DRUG: Nab paclitaxel|DRUG: paclitaxel
Sponsor: Akeso